Please login to the form below

Not currently logged in
Email:
Password:

patent challenge

This page shows the latest patent challenge news and features for those working in and with pharma, biotech and healthcare.

Biogen completes filing for highly-anticipated Alzheimer’s drug

Biogen completes filing for highly-anticipated Alzheimer’s drug

Biogen is relying heavily on the success of aducanumab, given that Mylan recently won a patent challenge allowing it to manufacture and sell a generic version of the former company’s

Latest news

  • Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in US Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in US

    Even more distressing, perhaps, for the US pharma company is the patent challenge from a team of Chinese scientists who allege they have improved and targeted the drug’s use against ... However, despite the challenges, experts have maintained that

  • Biogen triumphs over Mylan’s Tecfidera patent challenge Biogen triumphs over Mylan’s Tecfidera patent challenge

    Shares in Biogen skyrocketed by 32% following ruling. Biogen has scored its first major success of the year, winning a patent challenge from Mylan over its multiple sclerosis drug Tecfidera.  . ... The challenge from Mylan focused on Biogen’s ‘514

  • Biogen under fire over $88,000 Vumerity annual price Biogen under fire over $88,000 Vumerity annual price

    However, it is also under threat from a patent challenge levelled by generic drugmaker Mylan, which if it is successful, could shed years off Biogen’s marketing exclusivity for the drug ... Vumerity is Biogen’s answer to the patent pressures on

  • Triplet approvals for myeloma boost Celgene in Q2 Triplet approvals for myeloma boost Celgene in Q2

    Revlimid’s gains came despite the arrival the first lenalidomide generic in Europe from Alvogen, which was launched in February, although Celgene was able to fend off a patent challenge from

  • Tecfidera successor’s side-effect profile boosts Biogen Tecfidera successor’s side-effect profile boosts Biogen

    The strength of Vumerity’s safety and efficacy profile is of great importance to Biogen, not just because of new competitors in MS, but because of a patent challenge to Tecfidera. ... A challenge by Mylan is due in a US court next year, which if

More from news
Approximately 1 fully matching, plus 53 partially matching documents found.

Latest Intelligence

  • Pharma funding and M&A in 2020 Pharma funding and M&A in 2020

    The rationale for this is clear. Not least because of the challenge of patent cliffs for many traditional pharma businesses, the firms that wish to still be around in years to

  • Interview: Greg Perry, European Generic medicines Association Interview: Greg Perry, European Generic medicines Association

    Industry Challenges. Perry thinks that the biggest challenge the industry faces is sustainability. ... price.". Another challenge the generics industry has is the ability to get a product on the market immediately a patent expires.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Indians scalp cowboys in patent war

    claims?  . You can expect lawyers working for generics manufacturers to vigorously challenge the Allergan strategy. ... At the same time, imaginative patent lawyers will be racking their brains to exploit new opportunities.  .

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics